143 related articles for article (PubMed ID: 4970218)
1. Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice.
Brehmer W; Anacker RL; Ribi E
J Bacteriol; 1968 Jun; 95(6):2000-4. PubMed ID: 4970218
[TBL] [Abstract][Full Text] [Related]
2. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.
Jeevan A; Yoshimura T; Foster G; McMurray DN
Infect Immun; 2002 Mar; 70(3):1245-53. PubMed ID: 11854207
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
4. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis.
Ribi E; Meyer TJ; Azuma I; Parker R; Brehmer W
Cell Immunol; 1975 Mar; 16(1):1-10. PubMed ID: 803876
[No Abstract] [Full Text] [Related]
5. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C
J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894
[TBL] [Abstract][Full Text] [Related]
6. Effective nonliving vaccine against experimental tuberculosis in mice.
Ribi E; Larson C; Wicht W; List R; Goode G
J Bacteriol; 1966 Mar; 91(3):975-83. PubMed ID: 4956339
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv.
Anacker RL; Barclay WR; Brehmer W; Goode G; List RH; Ribi E; Tarmina DF
Am Rev Respir Dis; 1969 Feb; 99(2):242-8. PubMed ID: 4975012
[No Abstract] [Full Text] [Related]
8. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
[TBL] [Abstract][Full Text] [Related]
9. Aerosol immunization by alginate coated mycobacterium (BCG/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice.
Nagpal PS; Kesarwani A; Sahu P; Upadhyay P
BMC Infect Dis; 2019 Jul; 19(1):568. PubMed ID: 31262260
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
11. Effects of pretreatment of mice with BCG cell walls in saline on subsequent vaccination with BCG oil droplet vaccine.
Meyer TJ; Anacker RL; Ribi E
Cell Immunol; 1974 Oct; 14(1):52-65. PubMed ID: 4219589
[No Abstract] [Full Text] [Related]
12. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
Nikonenko BV; Mezhlumova MB; Moroz AM
Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
[TBL] [Abstract][Full Text] [Related]
13. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.
Bao L; Chen W; Zhang H; Wang X
Infect Immun; 2003 Apr; 71(4):1656-61. PubMed ID: 12654778
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.
Collins FM
Infect Immun; 1971 Dec; 4(6):688-96. PubMed ID: 5005311
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
16. Protection by live Mycobacterium habana vaccine against Mycobacterium tuberculosis H37Rv challenge in mice.
Prem Raj P; Srivastava S; Jain SK; Srivastava BS; Srivastava R
Indian J Med Res; 2003 Apr; 117():139-45. PubMed ID: 14604301
[TBL] [Abstract][Full Text] [Related]
17. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages.
McDonough KA; Kress Y; Bloom BR
Infect Immun; 1993 Jul; 61(7):2763-73. PubMed ID: 8514378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
